A Phase II Trial of Combination Cabazitaxel and Cisplatin Chemotherapy in the Neoadjuvant Treatment of Transitional Cell Carcinoma of the Urinary Bladder
Phase of Trial: Phase II
Latest Information Update: 24 Apr 2017
At a glance
- Drugs Cabazitaxel (Primary) ; Cisplatin (Primary)
- Indications Bladder cancer
- Focus Therapeutic Use
- 19 Apr 2017 Planned End Date changed from 1 May 2017 to 1 Jan 2018.
- 18 Apr 2017 Planned primary completion date changed from 1 May 2013 to 1 Sep 2017.
- 11 Jun 2012 Additional lead trial investigator identified as reported by ClinicalTrials.gov.